COM:PRECISIONBIOSCIENCES
Precision BioSciences, Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
precisionbiosciences.comcrunchbase
precision-bioscienceslinkedin
precision-biosciences-inc-founding date
Jan 01, 2006ipo date
Mar 28, 2019
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific type of immune cell is geneticall...Show More